These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 34267758)
21. Typical clinical and imaging manifestations of encephalitis with anti-γ-aminobutyric acid B receptor antibodies: clinical experience and a literature review. Si Z; Wang A; Liu J; Zhang Z; Hu K Neurol Sci; 2019 Apr; 40(4):769-777. PubMed ID: 30671737 [TBL] [Abstract][Full Text] [Related]
22. [Autoimmune encephalitis: possibilities in the laboratory investigation]. Böröcz K; Hayden Z; Mészáros V; Csizmadia Z; Farkas K; Kellermayer Z; Balogh P; Nagy F; Berki T Orv Hetil; 2018 Jan; 159(3):107-112. PubMed ID: 29332416 [TBL] [Abstract][Full Text] [Related]
23. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancaster E; Lai M; Peng X; Hughes E; Constantinescu R; Raizer J; Friedman D; Skeen MB; Grisold W; Kimura A; Ohta K; Iizuka T; Guzman M; Graus F; Moss SJ; Balice-Gordon R; Dalmau J Lancet Neurol; 2010 Jan; 9(1):67-76. PubMed ID: 19962348 [TBL] [Abstract][Full Text] [Related]
24. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis. Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y Front Neurol; 2020; 11():280. PubMed ID: 32431657 [No Abstract] [Full Text] [Related]
25. The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies. van Coevorden-Hameete MH; de Bruijn MAAM; de Graaff E; Bastiaansen DAEM; Schreurs MWJ; Demmers JAA; Ramberger M; Hulsenboom ESP; Nagtzaam MMP; Boukhrissi S; Veldink JH; Verschuuren JJGM; Hoogenraad CC; Sillevis Smitt PAE; Titulaer MJ Brain; 2019 Jun; 142(6):1631-1643. PubMed ID: 31009048 [TBL] [Abstract][Full Text] [Related]
26. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study. Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133 [TBL] [Abstract][Full Text] [Related]
27. Intrathecal B-cell activation in LGI1 antibody encephalitis. Lehmann-Horn K; Irani SR; Wang S; Palanichamy A; Jahn S; Greenfield AL; Dandekar R; Lepennetier G; Michael S; Gelfand JM; Geschwind MD; Wilson MR; Zamvil SS; von Büdingen HC Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32029531 [TBL] [Abstract][Full Text] [Related]
28. Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis. Liu CY; Zhu J; Zheng XY; Ma C; Wang X Mediators Inflamm; 2017; 2017():6361479. PubMed ID: 28698711 [TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and outcomes of patients with antibody-related autoimmune encephalitis presenting with disorders of consciousness: A prospective cohort study. Shan D; Zhang H; Cui L; Chai S; Chen W; Liu G; Tian F; Fan L; Yang L; Zhang Y Immun Inflamm Dis; 2024 Sep; 12(9):e70019. PubMed ID: 39315845 [TBL] [Abstract][Full Text] [Related]
30. A diagnostic approach for identifying anti-neuronal antibodies in children with suspected autoimmune encephalitis. Nakahara E; Sakuma H; Kimura-Kuroda J; Shimizu T; Okumura A; Hayashi M J Neuroimmunol; 2015 Aug; 285():150-5. PubMed ID: 26198933 [TBL] [Abstract][Full Text] [Related]
31. Cognitive impairments in autoimmune encephalitis: the role of autoimmune antibodies and oligoclonal bands. Rozenberg A; Shelly S; Vaknin-Dembinsky A; Friedman-Korn T; Benoliel-Berman T; Spector P; Yarovinsky N; Guber D; Gutter Kapon L; Wexler Y; Ganelin-Cohen E Front Immunol; 2024; 15():1405337. PubMed ID: 39403380 [TBL] [Abstract][Full Text] [Related]
32. Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy. Kishitani T; Matsunaga A; Ikawa M; Hayashi K; Yamamura O; Hamano T; Watanabe O; Tanaka K; Nakamoto Y; Yoneda M Medicine (Baltimore); 2017 Mar; 96(10):e6181. PubMed ID: 28272206 [TBL] [Abstract][Full Text] [Related]
33. Prozone phenomenon observed in indirect immunofluorescence assay by antibodies against neuronal antigens. Mathai A; Panicker S; Kannoth S; Anandakuttan A J Neuroimmunol; 2020 Dec; 349():577415. PubMed ID: 33032015 [TBL] [Abstract][Full Text] [Related]
34. Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature. Joubert B; Kerschen P; Zekeridou A; Desestret V; Rogemond V; Chaffois MO; Ducray F; Larrue V; Daubail B; Idbaih A; Psimaras D; Antoine JC; Delattre JY; Honnorat J JAMA Neurol; 2015 Oct; 72(10):1163-9. PubMed ID: 26280228 [TBL] [Abstract][Full Text] [Related]
35. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy. Levite M J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016 [TBL] [Abstract][Full Text] [Related]